(E)-2-(1-methyl-6-oxa-3-azoniaspiro[2.5]octan-2-yl)but-2-enedioic acid

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: (E)-2-(1-methyl-6-oxa-3-azoniaspiro[2.5]octan-2-yl)but-2-enedioic acid
• 化学式: C11H16NO5+
• 分子量: 242.25
• InChiKey: BAMCVLHARRXKHN-SOFGYWHQSA-O

计算性质

• 辛醇/水分配系数(LogP)：
  -0.7
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.64
• 拓扑面积：
  83.8
• 氢给体数：
  2
• 氢受体数：
  5

文献信息

• TREATMENT OF MULTIPLE SCLEROSIS AND PSORIASIS USING PRODRUGS OF METHYL HYDROGEN FUMARATE
  申请人：XenoPort, Inc.

  公开号：EP2854795A1

  公开（公告）日：2015-04-08
• [EN] TREATMENT OF MULTIPLE SCLEROSIS AND PSORIASIS USING PRODRUGS OF METHYL HYDROGEN FUMARATE<br/>[FR] TRAITEMENT DE LA SCLÉROSE EN PLAQUES ET DU PSORIASIS AU MOYEN DE PROMÉDICAMENTS DE FUMARATE DE MÉTHYLE-HYDROGÈNE
  申请人：XENOPORT INC

  公开号：WO2013181451A1

  公开（公告）日：2013-12-05

  Improved methods of treating multiple sclerosis and/or psoriasis using prodrugs of methyl hydrogen fumarate are disclosed. The methods comprise administering certain prodrugs of methyl hydrogen fumarate. The methods are able to achieve high blood plasma concentrations of the active metabolite, methyl hydrogen fumarate, without causing significant gastrointestinal irritation. New prodrugs of methyl hydrogen fumarate are also disclosed.